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ABSTRACT 
Oral candidosis is one of the commonest oral manifestations of HIV infection.  The 
objective of this study was to determine the prevalence of oral candidosis in relation to 
CD4 counts and use of antiretroviral drugs among Nigerian HIV infected patients. 
Design: A cross-sectional study in which an interviewer administered questionnaire was 
used to collect data from 244 consecutive HIV patients aged 16-65years. They were 
examined for oral lesions including Oral candidosis. The presumptive criteria as defined 
by ECC Clearing House were used for diagnosis of oral lesions. 
Result: Forty-six (18.9%) patients presented with oral candidosis of various types. 
Pseudomembraneous candidosis was the commonest variant seen in 60.0% of those who 
presented with intra oral candidosis. Prevalence of oral candidosis was significantly 
associated with use of antiretroviral drugs (p<0.05), low CD4 counts (p=0.010) and time 
since diagnosis (p=0.005). 
Conclusion: Prevalence of candidosis was found to indicate a worsening of HIV disease 
in the group of patients studied and use of antiretroviral drugs was associated with 
reduced prevalence. Oral candidosis could be a useful marker of patients with low CD4 
count. In view of this, emphasis should be placed on the importance of systematic 
examination of the oral cavity in all medical examination of HIV infected patients. 
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INTRODUCTION 
The oral cavity is an important source of 
diagnostic and prognostic information in 
patients with HIV infection 1. HIV 
infection has been associated with  
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various oral lesions which were 
classified by the EC Clearing house on 
oral problems related to HIV infection in 
19912. Oral candidosis is one of the 
lesions that were classified as “Lesions 
strongly associated with HIV infection” 
and it is an important marker of the 
progression of the infection. 
  It may indeed be the initial 
manifestation of the disease and it is the 
first sign of infection in about 10% of 
HIV infected adults3. Oral candidosis 
may present in several distinct variants 
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of which Pseudomembraneous 
candidosis and Erythematous candidosis 
are the most prevalent occurring in 20 – 
25% of patients 1. 
Oral candidosis frequently complicates 
HIV disease in Africa 4. Studies on the 
oral manifestations of HIV infection in 
Nigeria showed that candidosis was the 
most prevalent oral lesion accounting for 
80.0% of lesions seen in one study5. 
Other studies recorded a prevalence of 
between 33.3%6 and 36.4%7. 
Pseudomembraneous candidosis require 
host infection with a virulent species of 
candida8 and may occur very early in the 
course of HIV infection1 as well as in 
association with reducing CD4 counts 9. 
Also the use of HAART is said to reduce 
the incidence of HIV associated oral 
lesions such as candidosis10. Other 
factors that may affect the incidence of 
oral candidosis include malnutrition 
induced mucosal disruptions which 
when combined with poor oral hygiene 
are expressed as candidosis, angular 
cheilitis and severe periodontal 
disease11.  
The aim of this study was to describe the 
occurrence of oral candidosis in HIV 
infected persons in Nigeria. It also aims 
to describe the effect of the use of 
HAART and CD4 counts on the 
occurrence of oral candidosis.  
 
MATERIALS AND METHODS 
The study was carved out of a larger 
study of the oral manifestations of HIV 
and barriers to oral health care among 
HIV positive patients in Nigeria. Two 
hundred and forty four consecutive 
patients aged 16 – 65 years whose status 
had been confirmed prior to the time of 
examination who were attending 
dedicated clinics in two teaching 
hospitals in Lagos, Nigeria over a period 
of nine months were examined. Consent 
was sought and got from willing 
participants who were examined using 
an interviewer administered 
questionnaire. Information such as 
demographic characteristics, time since 
diagnosis, current medication and last 
recorded CD4 count were collected. 
Diagnosis of oral candidosis was made 
using the presumptive diagnostic criteria 
as defined by the EC Clearing House. 
Examination recorded presence or 
absence of oral lesions including oral 
candidosis.  Data analysis was done with 
EPI-info version 6.04 statistical 
software. Chi -square test of association 
was used to determine the significance 
of differences. Difference was taken as 
significant at the level of p<0.05. 
Multivariate analysis was used to 
construct a model in which the 
dependent variable was occurrence of 
oral candidosis and the independent 
variables were CD4 count, use of 




The ages of the patients ranged between 
16 and 65 years with a mean of 37.9 
years, SD 9.34. The majority were in the 
30 – 39year age group. One hundred and 
thirty seven (56.1%) were females while 
43.9% (n=107) were males. Table 1 
shows age and gender distribution of the 
patients. 
 
TABLE 1 : AGE AND GENDER  




FEMALE MALE TOTAL 
10 – 19 1 (0.7%) 0 (0.0%) 1 (0.4%) 
20 – 29 42 (30.7%) 3 (2.8%) 45 (18.4%) 
30 – 39 57 (41.6%) 48 (44.9%) 105 (43.0%) 
40 – 49 23 (16.8%) 39 (36.4%) 62 (25.4%) 
50 – 59 13 (9.5%) 13 (12.1%) 26 (10.7%) 
60 - 69  1 (20.0%) 4 (80.0%) 5 (2.0%) 
TOTAL 137 
(56.1%) 
107 (43.9%) 244 
 
Oral Candidosis and HIV - Agbelusi et al                          African Journal of oral Health 
                         Volume 2 Numbers 1 & 2 2006: 57-62 
 
Http://www.ajoh.org        ©African Journal of Oral Health  59 
Most of the patients had HIV1 (82.4%), 
1.6% had HIV2, 4.9% had a co- 
infection of HIV1 and HIV2 while 
11.1% were unspecified in the case 
notes. One hundred and eighty three 
(75%) of the patients were on 
antiretroviral drugs while 61 (25%) had 
not commenced therapy. 
 
PREVALENCE OF CANDIDOSIS 
Oral candidosis of various clinical forms 
were diagnosed in 18.9% (n=46) of the 
population. Table 2 shows the various 
clinical presentations.  
 
TABLE 2 : CLINICAL PRESENTATIONS  
OF ORAL CANDIDOSIS 
 
Pseudomembraneous candidosis was the 
most prevalent form seen in 60% (n = 
24) of the patients. Angular cheilitis was 
diagnosed in 7.4% (n=18) of the patients 
while chronic hyperplastic candidosis 
was not diagnosed in any of the patients.  
Table 3 shows the intra-oral 
presentations of candidosis diagnosed in 
the study population.  
 









ERYTHEMATOUS 14 35.0 
MIXED 2 5.0 
TOTAL 40 100 
 
 The use of antiretroviral drugs was 
significantly associated with the 
prevalence of candidosis. Fewer of the 
patients on antiretroviral therapy 
presented with candidosis, while a 
majority 60.9% (n= 28) of those not on 
therapy had candidosis (P < 0. 05). This 
is shown on Table 4. 
 
TABLE4: THE ASSOCIATION BETWEEN 
ANTIRETROVIRAL DRUGS AND THE 
PREVALENCE OF CANDIDOSIS. 
Mantel Haenszel  X2  = 38.74 
P= 0.00000. 
 
 CD4 counts were recorded for 84.42% 
(n = 206) of the patients while it was 
unavailable for the others. The CD4 
counts ranged between 20 and 
650cells/mm3.   Most of the patients with 
diagnosed oral candidosis had low CD4 
counts (CD4 less than 300) while none 
of the patients whose CD4 was above 
500/mm3 presented with candidosis. 
This was statistically significant ( p = 
0.010). This is shown on Table 5.  
 
TABLE 5: EFFECT OF CD4 ON 
PREVALENCE OF CANDIDOSIS. 
 
 X2 = 11.30, df = 3, p = 0.01 
 
Majority of the Pseudomembraneous 
candidosis was diffused while a few 
were localised. Patients whose CD4 









CANDIDOSIS AND  
ANGULAR CHEILITIS 
12 4.9 
ANGULAR   
CHEILITIS ONLY 
6 2.6 
NO CANDIDOSIS 198 81.1 
TOTAL 244 100 









33 (54.1%) 28 (45.9%) 61 (100.0%) 
ON ARV 165 (90.2%) 18 (9.8%) 183 (100.0%) 









0 - 200 28 (71.8%) 11 (28.2%) 39 (100.0%) 
201- 300 97 (85.8%) 16 (14.2%) 113(100.0%) 
301- 500 47 (96.0%) 2 (4.0%) 49 (100.0%) 
ABOVE 
500 
5 (100.0%) 0 (0.0%) 5 (100.0%) 
TOTAL 177(85.9%) 29 (14.1%) 206 (100%) 
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 Time since diagnosis ranged between 1 
and 96 months with a mean of 19.46, SD 
19.8 months and median 12.0. Majority 
115 (47.1%) of the patients were 
diagnosed in the last one year.  There 
was a statistically significant association 
between time since diagnosis and 
prevalence of oral candidosis (p = 
0.005). Majority of the patients who 
presented with candidosis were 
diagnosed in the last one year.  
There was no significant association 
between occurrence of candidosis and 
other variables such as age, sex, and type 
of HIV infection. 
Multivariate analysis showed that low 
CD4 counts and use of antiretroviral 
drugs were significant variables. 
 
DISCUSSION 
Oral candidosis is one of the most 
common oral fungal diseases seen in 
association with HIV infection4. It may 
be the first presenting sign of HIV 
disease and an important marker of 
disease progression12. As the prevalence 
of HIV infection is continually 
increasing in Nigeria, the dentist may be 
the first health care professional to 
recognise the manifestation of HIV in an 
undiagnosed HIV infected patient. 
Dentists therefore must be prepared to 
recognise oral manifestations in an 
undiagnosed HIV infected patient. 
The prevalence of oral candidosis among 
the group of HIV patients studied was 
18.9%. 
 Pseudomembraneous candidosis was the 
most common variant (60.0%) 
diagnosed in the group. This is similar to 
other Nigerian studies 6,7 and indeed to 
findings in other parts of the world 13,14 
The Erythematous variety was found in 
35% of the patients with intraoral 
candidosis and mostly as depapilation of 
the dorsum of the tongue. Both the 
erythematous and pseudomembraneous 
forms have been associated with 
increased risk for the subsequent 
development of opportunistic infections 
classifying the patient as having AIDS as 
defined by the Centre for Disease 
Control 15.      
 
The introduction of Highly Active 
Antiretroviral Therapy (HAART) 
appears to have reduced the incidence of 
HIV related oral lesions and in a 
prospective study, oral candidosis was 
virtually eliminated with the use of 
HAART3. 
 
Currently antiretroviral therapy (ART), 
and HAART are combination therapies 
of three or more drugs that delay the 
onset of AIDS. The patients in our study 
were on the triple drug therapy 
consisting of two Nucleoside reverse 
transcriptase inhibitors and a Non-
nucleoside transcriptase inhibitor. There 
was a significant reduction in the 
prevalence of Candida infection with the 
use of antiretroviral drugs in the 
population studied. This is in agreement 
with previous studies. In the United 
Kingdom study, prevalence of oral 
manifestations including oral candidosis 
was significantly reduced in subjects on 
dual and triple therapy in comparison 
with patients on monotherapy or no 
therapy 16,17. 
 
Time since diagnosis, which appeared to 
be significantly associated with 
prevalence of candidosis, may be 
because of the therapy patients have 
under gone, as prevalence of candidosis 
reduced with increased time since 
diagnosis. Its confounding significance 
was eliminated in the multivariate 
analysis. 
 
The CD4 cell count is a very useful 
laboratory tool to monitor the course of 
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HIV induced immune deficiency. A CD4 
count of 200cells/mm3 marks an 
especially important point in the course 
of HIV infection, as it is the AIDS 
indicator count. 
The majority of the patients who 
presented with candidosis in our study 
had low CD4 counts (0 – 300cells/mm3). 




The prevalence oral candidosis in this 
study was 18.9% .The use of ART was 
found to significantly reduce the 
prevalence of oral candidosis but rises 
with decreasing CD4 counts. 
Prevention and early treatment of 
opportunistic infections like candidosis 
are especially important in HIV patients 
to maintain quality of life and possibly 
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